Ignite Creation Date:
2025-12-24 @ 11:14 PM
Ignite Modification Date:
2026-01-04 @ 4:07 PM
Study NCT ID:
NCT03684356
Status:
UNKNOWN
Last Update Posted:
2020-02-18
First Post:
2018-09-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Comparison of Peri-implant Tissues Using Socket Shield Technique Versus Xenograft
Sponsor:
Cairo University
Organization:
Study Overview
Official Title:
Comparison of the Dimensional Changes of Hard and Soft Peri-implant Tissues Around Single Immediate Post-Extraction Implants in the Esthetic Zone With Socket Shield Technique Versus Using Xenograft: A Randomized Controlled Clinical Trial
Status:
UNKNOWN
Status Verified Date:
2020-02
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this study is to clinically and radiographically evaluate the dimensional changes of soft and hard peri-implant tissues around single immediate post-extraction implants in the esthetic zone.
Detailed Description:
to compare the efficacy of the socket shield technique in counteracting the dimensional changes of the soft and hard peri-implant tissues to filliing the buccal gap with xenograft.
* Population (P): Patients with single non-restorable tooth in the esthetic zone.
* Intervention (I): Immediate implant placement with socket shield technique.
* Comparator (C): Immediate implant placement and filling the buccal gap with xenograft.
* Primary Outcome (O): Pink Esthetic Score (PES) (Fürhauser et al., 2005).
* Time frame: 9 months (Chu et al., 2015).
* Study design: Randomized controlled clinical trial.
* Population (P): Patients with single non-restorable tooth in the esthetic zone.
* Intervention (I): Immediate implant placement with socket shield technique.
* Comparator (C): Immediate implant placement and filling the buccal gap with xenograft.
* Primary Outcome (O): Pink Esthetic Score (PES) (Fürhauser et al., 2005).
* Time frame: 9 months (Chu et al., 2015).
* Study design: Randomized controlled clinical trial.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: